Center Laboratories, Inc. (TPEX: 4123)
Taiwan
· Delayed Price · Currency is TWD
50.20
+1.15 (2.34%)
Nov 20, 2024, 1:30 PM CST
Center Laboratories Company Description
Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally.
It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses.
The company also supplies glass fibre pressure vessels. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.
Center Laboratories, Inc.
Country | Taiwan |
Founded | 1959 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Su-Chi Wang |
Contact Details
Address: No. 3-2, Yuanyuan Street Taipei City, 115 Taiwan | |
Phone | 886 2 2655 8680 |
Website | centerlab.com.tw |
Stock Details
Ticker Symbol | 4123 |
Exchange | Taipei Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | TW0004123005 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Su-Chi Wang | Chief Executive Officer, Chief Investment Officer, Chief Operating Officer and Chairman |
Min-Li Lien | Assistant Vice President of Legal Affairs Department |
Jui-Pao Hsu | General President of Pharmaceutical Business |
Ching-Yu Tang | Head of Corporate Governance |
Chiun-Yu Lin | Plant Director |
An-Ni Mao | Manager of Finance and Accounting Department |
Hsiu Yueh Lin | Director of Administration Department |